Cannabinoid Encyclopedia Plain-English research
New here? Search a cannabinoid or health question. Read the simple version. Open PubMed links when you want proof. This is education, not medical advice.

Dictionary / Product identity

Isolate

Single-compound product language that should not be mixed with extract evidence.

Dictionary A-Z Evidence Method
Product identityterm category
6related public pages
editorial navigationdefinition status
draftreview status
16exact evidence rows
10exact source links
297nearby evidence rows
266nearby source links
2do-not-confuse links
0entity links

This page is a dictionary definition and navigation aid. Exact evidence rows below come from approved workbench claims; broader claims and citations live on the related source-backed pages.

Dictionary Reader Map

Use the definition as a doorway, not a conclusion.

Isolate explains vocabulary used across the cannabinoid encyclopedia. The definition orients the reader; exact rows and related pages carry the source-backed claims.

Definition Role Product identity

Product terms keep extracts, isolates, mixtures, and testing separate.

Exact Evidence 16 rows

10 direct sources linked to approved workbench claims. PubMed 30374683

Nearby Graph 6 pages

297 nearby evidence rows and 266 nearby source links.

Also Search isolated compound, purified cbd, purified compound

Aliases help readers find the same concept without changing the evidence standard.

Plain-Language Definition

What it means here

Isolate is used in this encyclopedia as a product identity term. Single-compound product language that should not be mixed with extract evidence.

Product-identity terms describe what material was studied or sold. They are important because isolated compounds, extracts, mixtures, and commercial products should not be treated as interchangeable.

Also searched as: isolated compound, purified cbd, purified compound.

Do not confuse with:

Broad spectrum1 row Full spectrum0 rows

Evidence Guardrail

How to read it without overreaching

Do not borrow evidence from one product identity and apply it to another. Extracts, isolates, mixtures, contaminants, batch testing, and labels can change what a source actually supports.

Evidence Lens

What this term can currently point to

Exact rows 16

Direct approved claim rows linked to this dictionary term. PubMed 30374683

Exact sources 10

Distinct source records under those exact rows. PubMed 30374683

Related pages 6

Source-backed public pages where this vocabulary is likely useful. Open related page

Nearby rows 297

Evidence rows available on those related public pages. Open related page

Exact rows are direct evidence links. Use them first, then use related pages to understand the broader research context.

Source Path

How to move from this definition to research

  1. Read the definition.Use it to understand the vocabulary in plain English.
  2. Check exact rows.When direct rows exist, open the linked PubMed or DOI record. PubMed 30374683
  3. Open related pages.Use nearby pages for broader source-backed context. Related page
  4. Keep the boundary.Do not transfer evidence from one product identity to another without source support.

Exact Evidence Rows

Approved source-backed rows linked to this term

Evidence method

16 exact rows

Evidence Group

Insufficient

5 exact rows / 4 sources

Evidence row 188 / uses term

CBD studied for pregnancy, lactation, pediatric, adolescent, or developmental contexts.

insufficient / very_low confidence.

Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome. PubMed 33754312

Claim or source metadata contains an explicit term marker.

Evidence row 196 / uses term

CBD studied for safety, adverse-event, impairment, or formulation-specific concerns.

insufficient / very_low confidence.

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. PubMed 30374683

Claim or source metadata contains an explicit term marker.

Evidence row 199 / uses term

CBD studied for safety, adverse-event, impairment, or formulation-specific concerns.

insufficient / very_low confidence.

Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy. PubMed 33667843

Claim or source metadata contains an explicit term marker.

Evidence row 200 / uses term

CBD studied for safety, adverse-event, impairment, or formulation-specific concerns.

insufficient / very_low confidence.

Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access program. PubMed 37593907

Claim or source metadata contains an explicit term marker.

Evidence row 383 / uses term

CBD studied for Seizure and neurodevelopmental outcomes.

insufficient / very_low confidence.

Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome. PubMed 33754312

Claim or source metadata contains an explicit term marker.

Back to evidence groups

Evidence Group

Preclinical

1 exact row / 1 source

Evidence row 731 / uses term

CBC studied for neurobehavioral, mood, neural stem cell, or neurogenesis outcomes.

preclinical / very_low confidence.

Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. PubMed 20332000

Claim or source metadata contains an explicit term marker.

Back to evidence groups

Evidence Group

Mechanistic or Pharmacological

10 exact rows / 6 sources

Evidence row 47 / uses term

CBD interacts with drug or class drug-interaction mechanisms or safety-relevant outcomes.

mechanistic or pharmacological / very_low confidence.

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. PubMed 30374683

Claim or source metadata contains an explicit term marker.

Evidence row 80 / uses term

THCV studied for Appetite and metabolic outcomes.

mechanistic or pharmacological / very_low confidence.

In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. PubMed 33230154

Claim or source metadata contains an explicit term marker.

Evidence row 540 / uses term

CBG studied for Pain-related outcomes.

mechanistic or pharmacological / very_low confidence.

In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. PubMed 33230154

Claim or source metadata contains an explicit term marker.

Evidence row 621 / uses term

CBG studied for Appetite and metabolic outcomes.

mechanistic or pharmacological / very_low confidence.

In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. PubMed 33230154

Claim or source metadata contains an explicit term marker.

Evidence row 631 / uses term

CBG studied for Appetite and metabolic outcomes.

mechanistic or pharmacological / very_low confidence.

Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus. PubMed 31941059

Claim or source metadata contains an explicit term marker.

Evidence row 691 / uses term

CBC studied for Pain-related outcomes.

mechanistic or pharmacological / very_low confidence.

In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. PubMed 33230154

Claim or source metadata contains an explicit term marker.

Evidence row 798 / uses term

THCV studied for Pain-related outcomes.

mechanistic or pharmacological / very_low confidence.

In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. PubMed 33230154

Claim or source metadata contains an explicit term marker.

Evidence row 1038 / uses term

Cannabinoids modulates TRPA1.

mechanistic or pharmacological / very_low confidence.

Affinin, Isolated from Heliopsis longipes, Induces an Antihypertensive Effect That Involves CB1 Cannabinoid Receptors and TRPA1 and TRPV1 Channel Activation. PubMed 38219731

Claim or source metadata contains an explicit term marker.

Evidence row 1152 / uses term

Noladin ether studied for noladin ether biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms.

mechanistic or pharmacological / very_low confidence.

Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor. PubMed 15148262

Claim or source metadata contains an explicit term marker.

Evidence row 1163 / uses term

Virodhamine studied for virodhamine biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms.

mechanistic or pharmacological / very_low confidence.

Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery. PubMed 15233865

Claim or source metadata contains an explicit term marker.

Back to evidence groups

Source-Backed Connections

Related pages in the current encyclopedia

All terms
compound CBD 166 evidence rows / 139 sources topic CBD and seizure-related outcomes review 27 evidence rows / 27 sources topic CBD and sleep-related outcomes review 12 evidence rows / 12 sources compound CBDV-A 44 evidence rows / 40 sources compound CBDA 26 evidence rows / 26 sources compound CBDV 22 evidence rows / 22 sources

Nearby Terms

Same dictionary category

Broad spectrum1 row Certificate of analysis0 rows Full spectrum0 rows